IDEAYA Biosciences, Inc. (IDYA) Stock

About IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. (IDYA) stock trades at $34.71 with a market capitalization of $3.35B. The stock is valued at a negative price-to-earnings (P/E) ratio of -19.46, reflecting a net loss over the last twelve months, price-to-book of 2.87, price-to-sales of 15.17. Over the past 52 weeks the stock has ranged between $26.05 and $42.68, and currently trades 18.7% below its 52-week high.

On profitability, IDEAYA Biosciences, Inc. generates a return on equity (ROE) of -16.47% (negative, reflecting a net loss), return on capital employed of -17.68%, an operating margin of -72.60%, a net profit margin of -74.75%.

IDEAYA Biosciences, Inc. by the numbers, 2017–2025

Between 2017 and 2025 IDEAYA Biosciences, Inc. reported revenue of $0 rising to $219.0M. Compounded, revenue has grown 61.4% a year over five years, 62.5% over three, 3028.6% over the last twelve months. Net profit fell to $-114.0M.

The most recent net margin is -74.75%. On a trailing twelve-month basis to Jun '26, revenue is $235.0M and net profit $-175.0M.

Borrowings rose from $3.0M to $28.0M, cash from operations was $-71.0M in the latest year, positive in 1 of the last 9.

Return on equity has averaged -17.7% over five years, and was -11.1% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

IDEAYA Biosciences, Inc. (IDYA) — frequently asked questions